
They owe around Rs 3,500 crore to Daiichi Sankyo after a Singaporean tribunal found them guilty of luring the Japanese drug maker to purchase Ranbaxy by withholding information.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MsbYAN
via
IFTTT
0 comments:
Post a Comment